Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Peter H. Langsjoen"'
Autor:
Peter H Langsjoen, Abdullah A Alabdulgader, David M. Diamond, Uffe Ravnskov, Sherif Sultan, Malcolm Kendrick, Tomohito Hamazaki, Kilmer S. McCully, Rokuro Hama, Michel de Lorgeril, Zoë Harcombe, Harumi Okuyama, Björn Hammarskjöld, Ralf Sundberg
Publikováno v:
Expert Review of Clinical Pharmacology. 13:1289-1294
Introduction: The European Society of Cardiology and European Atherosclerosis Society (ESC/EAS) have recently published three major revisions of their guidelines for the management of chronic heart disease, blood lipids, and diabetes. Areas covered:
Autor:
Yoko Hashimoto, Naoki Ohara, Yoichi Ogushi, Shunji Natori, Kenjiro Tatematsu, Daisuke Miyazawa, Shiro Watanabe, Nakamura, Hajime Uchino, Tomohito Hamazaki, Tetsuyuki Kobayashi, Harumi Okuyama, Mikio Kentaro Oh-hashi, Sheriff Sultan, Peter H. Langsjoen, Rokuro Hama
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::417e19afb4ebcc1da0a7d12e5628a3cc
https://doi.org/10.3390/books978-3-03943-946-1
https://doi.org/10.3390/books978-3-03943-946-1
Autor:
Harumi Okuyama, Niamh Hynes, Tore Scherstén, David M. Diamond, Uffe Ravnskov, Michel de Lorgeril, Rokuro Hama, Peter H Langsjoen, Paul J. Rosch, Sherif Sultan, Malcolm Kendrick, Ralf Sundberg, Kilmer S. McCully, Tomohito Hamazaki, Luca Mascitelli, Björn Hammarskjöld
Publikováno v:
Expert Review of Clinical Pharmacology. 11:959-970
For half a century, a high level of total cholesterol (TC) or low-density lipoprotein cholesterol (LDL-C) has been considered to be the major cause of atherosclerosis and cardiovascular disease (CVD), and statin treatment has been widely promoted for
Publikováno v:
The Permanente Journal. 23
CONTEXT Heart failure (HF) is rapidly increasing in incidence and is often present in patients receiving long-term statin therapy. OBJECTIVE To test whether or not patients with HF on long-term statin therapy respond to discontinuation of statin ther
Publikováno v:
The Permanente journal. 23
CONTEXT: Heart failure (HF) is rapidly increasing in incidence and is often present in patients receiving long-term statin therapy. OBJECTIVE: To test whether or not patients with HF on long-term statin therapy respond to discontinuation of statin th
Autor:
Ralf Sundberg, Harumi Okuyama, Luca Mascitelli, Paul J. Rosch, Malcolm Kendrick, Kilmer S. McCully, Peter H Langsjoen, Björn Hammarskjöld, Tomohito Hamazaki, Michel de Lorgeril, Rokuro Hama, Tore Scherstén, David M. Diamond, Niamh Hynes, Sherif Sultan, Uffe Ravnskov
Publikováno v:
Expert Review of Clinical Pharmacology. 12:93-94
We thank the authors for their interest in our paper and wish to expand upon the issues they raised in their letter. Our paper presents strong arguments against the general view that high LDL-chole...
Autor:
Alena M. Langsjoen, Peter H. Langsjoen
Publikováno v:
Clinical Pharmacology in Drug Development. 3:13-17
The bioavailability of the reduced form of coenzyme Q10 (ubiquinol) was compared to oxidized coenzyme Q10 (ubiquinone) with identical soft gel capsule excipients by measuring steady state plasma coenzyme Q10 (CoQ10 ) levels in 12 healthy volunteers.
Autor:
Tore Scherstén, Paul J. Rosch, Niamh Hynes, Björn Hammarskjöld, Peter H Langsjoen, David M. Diamond, Harumi Okuyama, Yoichi Ogushi, Uffe Ravnskov, Rokura Hama, Malcolm Kendrick, Ralf Sundberg, Sherif Sultan, Kilmer S. McCully, Tomohito Hamazaki, Luca Mascitelli, Aseem Malhotra
Publikováno v:
BMJ Open
Objective It is well known that total cholesterol becomes less of a risk factor or not at all for all-cause and cardiovascular (CV) mortality with increasing age, but as little is known as to whether low-density lipoprotein cholesterol (LDL-C), one c
Autor:
Tomohito Hamazaki, Alena M. Langsjoen, Peter H. Langsjoen, Tetsuyuki Kobayashi, Harumi Okuyama, Yoko Hashimoto, Satoshi Yoshida, Naoki Ohara
Publikováno v:
Pharmacology. 98(3-4)
Background: Positive associations have been observed between cardiovascular disease (CVD) and type 2 diabetes mellitus (DM), but their causal relationship has not been clarified. Nevertheless, guidelines from relevant medical societies recommend usin
Autor:
Peter H. Langsjoen, Alena M. Langsjoen
Publikováno v:
BioFactors. 32:119-128
Patients with CHF, NYHA class IV, often fail to achieve adequate plasma CoQ10 levels on supplemental ubiquinone at dosages up to 900 mg/day. These patients often have plasma total CoQ10 levels of less than 2.5 microg/ml and have limited clinical impr